Interestingly, the data from TCGA databases showed that the reduction of SLC39A8 expression was mainly occurred in patients with advanced ccRCC, while the expression level in patients with early ccRCC remained unchanged, even slightly increased. The gene discussed is SLC39A8; the disease is nonpapillary renal cell carcinoma.